Can portal vein thrombosis be treated?

Portal vein thrombosis (PVT) is a clinical hepatic disorder characterized by thrombus formation in the main trunk of the portal vein, superior mesenteric vein, inferior mesenteric vein, or splenic vein. Its etiology is complex, with most cases directly associated with increased blood viscosity and vascular wall injury.

Can portal vein thrombosis be treated?

Clinical manifestations vary depending on the speed of disease progression and the extent of vascular involvement, primarily presenting as progressively worsening portal hypertension and varying degrees of hepatic dysfunction. Common underlying causes include cirrhosis, intra-abdominal infection, hepatobiliary malignancies, pancreatitis, and genetic factors. PVT is a critical and life-threatening condition requiring prompt intervention.

Medical thrombolytic and anticoagulant therapy: In the absence of clear contraindications, thrombolytic therapy should be initiated immediately. Currently used agents include urokinase, streptokinase, low-molecular-weight heparin, aspirin, and warfarin.

Interventional vascular therapy: This is widely accepted as an effective method for restoring portal venous flow and includes catheter-directed thrombolysis and stent placement.

Surgical treatment: This represents the most direct therapeutic approach and includes procedures such as portal vein thrombectomy and superior mesenteric vein thrombectomy.

Prevention of PVT focuses on addressing both local and systemic risk factors. Commonly used prophylactic anticoagulants include aspirin, warfarin, and heparin. Traditional Chinese medicine preparations—such as Salvia miltiorrhiza extracts—and ligustrazine hydrochloride are also frequently employed.

Once PVT is diagnosed clinically, active treatment should be promptly initiated, with therapeutic modality selection tailored to individual patient circumstances to prevent complications.

We hope the above information is helpful to you. Wishing you good health and happiness!